ACTINIUM PHARMACEUTICALS, INC. Advance Royalties
ACTINIUM PHARMACEUTICALS, INC. (ATNM) had Advance Royalties of $35.00 million as of 2022-05-31, per its 10-Q filed 2024-08-05.
Financial Statements › Notes
us-gaap:AdvanceRoyalties · last filed 2024-11-14
- 2022-05-31: Advance Royalties $35.00M.
- 2022-04-07: Advance Royalties $35.00M.
| Period end | Advance Royalties |
|---|---|
| 2022-05-31 | $35.00M 10-Q · filed 2024-08-05 |
| 2022-04-07 | $35.00M 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |